Philip L. Wickens
Bayer (United States)(US)Bayer (Germany)(DE)
Publications by Year
Research Areas
Sulfur-Based Synthesis Techniques, HIV/AIDS drug development and treatment, Chemical Synthesis and Reactions, Synthesis and Characterization of Heterocyclic Compounds, DNA and Nucleic Acid Chemistry
Most-Cited Works
- → Quinazolinone Derivatives as Orally Available Ghrelin Receptor Antagonists for the Treatment of Diabetes and Obesity(2007)157 cited
- → PDE-10A inhibitors as insulin secretagogues(2007)35 cited
- → Small molecule inhibitors of IKK kinase activity(2005)34 cited
- → Synthesis of 2‘,3‘-Didehydro-2‘,3‘-dideoxynucleosides by Reaction of 5‘-Protected Nucleoside 2‘,3‘-Dimesylates with Telluride Dianion: A General Route from Cis Vicinal Diols to Olefins(1996)34 cited
- → Preparation of a Semisynthetic Analog of Mevinolin and Compactin(1995)20 cited
- → Indanylacetic acids as PPAR-δ activator insulin sensitizers(2007)11 cited
- → Synthesis of 2‘,3‘-Didehydro-2‘,3‘-dideoxynucleosides by Reaction of 5‘-O-Protected Nucleoside 2‘,3‘-Dimesylates with Lithium Areneselenolates(1997)11 cited
- → SAR of a novel ‘Anthranilamide Like’ series of VEGFR-2, multi protein kinase inhibitors for the treatment of cancer(2007)11 cited
- → Reaction of cis-vicinal dimethanesulfonates with Te2–: a method for converting cis-vicinal diols into olefins and its use in the preparation of 2′,3′-didehydro-2′,3′-dideoxynucleosides(1993)7 cited
- → ChemInform Abstract: Synthesis of 2′,3′‐Didehydro‐2′,3′‐dideoxynucleosides by Reaction of 5′ ‐Protected Nucleoside 2′,3′‐Dimesylates with Telluride Dianion: A General Route from cis Vicinal Diols to Olefins.(1997)